ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: David Kessler Nominated For FDA; Salahuddin Sentenced to Research; B.J. Kennedy Honored

October 26, 1990

NCCS Appointment Marks Transition To New Structure.

March 17, 2000

ONF Seeks Applications For Grants In Fatigue

March 31, 1995

In Brief: Thomas, Murray share Nobel Prize for Medicine; Wynder To Present Carese Memorial Lecture

October 12, 1990

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

In Brief: Clinton Signs FY95 Apparitions Into Law, to Seek $12 Billion Recision; NIH CUTS Likely

October 29, 1993